GoodRx Holdings (GDRX) Other Non-Current Assets (2019 - 2026)

GoodRx Holdings has disclosed Other Non-Current Assets across 8 years of filings, most recently posting $29.6 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $29.6 million, up 29.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.6 million (up 29.56% YoY), and the FY2025 annual result was $29.1 million, up 23.7% from the prior year.
• Other Non-Current Assets came in at $29.6 million for Q1 2026 at GoodRx Holdings, up from $29.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $44.5 million in Q2 2023 to a low of $20.9 million in Q1 2022.
• The 5-year median for Other Non-Current Assets is $29.6 million (2026), against an average of $31.5 million.
• Across the five-year window, Other Non-Current Assets soared 1603.9% in 2022 and plunged 37.92% in 2025, its largest moves.
• GoodRx Holdings' Other Non-Current Assets stood at $27.2 million in 2022, then surged by 39.06% to $37.8 million in 2023, then tumbled by 37.74% to $23.5 million in 2024, then gained by 23.7% to $29.1 million in 2025, then advanced by 1.61% to $29.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $29.6 million (Q1 2026), $29.1 million (Q4 2025), and $23.3 million (Q3 2025), per Business Quant data.